2021 Webinars – December

December 15

Topic: Psychedelic-assisted Psychotherapy to Treat Psychiatric and Existential Distress in Advanced Cancer

Historical open-label research in hundreds of participants, conducted in the 1960s, suggested a role of LSD-assisted psychotherapy to treat anxiety, depression, fear of death and pain in patients with end-of-life cancer. In the last decade, a growing body of research is pointing to the efficacy of psilocybin-assisted psychotherapy to treat anxiety, depression, suicidal ideation, and existential distress in people with advanced cancer.

Stephen Ross, MD
NYULH Center for Psychedelic Medicine
Associate Professor of Psychiatry and Child & Adolescent Psychiatry
Associate Director, NYULH Center for Psychedelic Medicine
NYU Grossman School of Medicine